Samar Sayedyahossein

Samar Sayedyahossein, M.D., Ph.D., is a senior research scientist at the Fralin Biomedical Research Institute at Virginia Tech Carilion (VTC), where she is a key member of the Mulvaney Lab. She holds dual degrees in medicine and molecular biology, contributing her expertise to cutting-edge cancer research.

Her research focuses on cancer biology and cell signaling, with a specialization in understanding and therapeutically targeting enzyme-substrate interactions in cancer. This work lies at the intersection of molecular oncology and drug discovery, aiming to identify novel mechanisms for cancer intervention.

The Mulvaney Lab is part of the Fralin Biomedical Research Institute's Cancer Research Center located at the Children's National Research & Innovation Campus in Washington, D.C., facilitating collaborative and translational research.

Samar's scientific background includes advanced training and research experience at the National Institutes of Health before joining Virginia Tech. Her doctoral work at Western University in Canada further solidified her expertise in molecular mechanisms of cancer.

While no specific awards or publications are listed in the provided text, her ongoing work in a prominent research lab suggests active contributions to the field of oncology and biomedical science.